门诊全膝关节置换术后连续收肌管阻滞的双盲随机安慰剂对照试验
本研究为双盲随机对照试验,纳入60例择期全膝关节置换患者,比较连续收肌管阻滞(CACB)与单次收肌管阻滞(SACB)在门诊或短住院设置下的恢复质量与镇痛效果。主要结局为术后第2天QoR-15评分,CACB组在术后第1、2、3天的QoR-15评分均显著高于SACB组,且阿片类药物消耗和静息及运动疼痛评分更低,无严重并发症或局麻药全身毒性征象。结论支持CACB在加速康复TKA路径中更广泛应用。
要点
- CACB组术后第1、2、3天QoR-15评分均显著高于SACB组。
- CACB组术后前3天阿片消耗量及静息/运动疼痛评分更低。
- 未见严重并发症或局麻药全身毒性征象。
核心结论
- 在门诊或短住院设置下,CACB较SACB显著改善TKA术后早期恢复质量和镇痛效果,支持在加速康复TKA路径中更广泛应用。
研究设计与样本
- 双盲随机安慰剂对照试验,纳入60例择期初次全膝关节置换患者,随机分为CACB组(30例)和SACB组(30例)。
- 主要结局为术后第2天QoR-15评分;次要结局包括阿片消耗、疼痛评分、住院时间和并发症。
主要发现
- CACB组术后第1天QoR-15评分为128.83±12.36,SACB组为109.00±15.90,p<0.001。
- CACB组术后第2天QoR-15评分为131.27±10.23,SACB组为110.86±15.37,p<0.001。
- CACB组术后第3天QoR-15评分为131.97±13.94,SACB组为111.18±18.28,p<0.001。
- CACB组术后前3天阿片消耗量及静息和运动疼痛评分均低于SACB组。
- 未观察到严重并发症或局麻药全身毒性征象。
临床怎么用
- 在门诊或短住院TKA患者中,可考虑采用CACB替代SACB以改善早期恢复质量和镇痛。
- CACB有助于减少术后前3天阿片消耗和疼痛评分,契合加速康复路径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total knee arthroplasty (TKA) is a widely performed procedure, with postoperative pain presenting as a major barrier to early mobilization and patient satisfaction. While single-injection adductor canal blocks (SACB) offer effective short-term analgesia, their limited duration often leads to rebound pain. Continuous adductor canal blocks (CACB) extend analgesic effects but are underexplored in outpatient settings. The objective of this study is to assess whether CACB improves quality of recovery and analgesia, in comparison to SACB in an outpatient or short-stay setting for TKA patients. METHODS: Double-blind randomized controlled trial comparing the Quality of Recovery-15 (QoR-15) score on postoperative day (POD) 2 (primary outcome) and opioid consumption, pain scores, hospital length-of-stay, and complications (secondary outcomes), between patients receiving CACB and SACB, when undergoing primary TKA. RESULTS: 60 patients were enrolled and randomized to two treatment groups: CACB (30) and SACB (30). Patients in the CACB group had significantly higher QoR-15 scores at PODs 1 (128.83±12.36 vs 109.00±15.90, p<0.001), 2 (131.27±10.23 vs 110.86±15.37, p<0.001) and 3 (131.97±13.94 vs 111.18±18.28, p<0.001). They also had lower opioid consumption and pain scores at rest and with movement during the first three PODs. No major complications or signs of local anesthetic systemic toxicity were observed. CONCLUSIONS: In our study, CACB significantly enhanced early postoperative recovery and analgesia following TKA in an outpatient or short-stay setting, compared with SACB, and these results support its broader adoption in fast-track TKA pathways.
引用
- Gleicher Y, Dos Santos Fernandes H, Peacock S, et al. Outpatient continuous adductor canal block (CACB) for total knee arthroplasty: a double-blinded randomized placebo-controlled trial. Reg Anesth Pain Med. 2025. PMID: 40935408. doi:10.1136/rapm-2025-106991
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。